WithdrawnNCT02800083
A Trial Evaluating Pitolisant (BF2.649) in Addiction Treatment
Researchers are comparing Pitolisant (BF2.649) and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Medication studyAges 18–65
Understand this study
What is this study about?
Researchers are comparing Pitolisant (BF2.649) and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Who could participate?
Listed age limits: 18 years to 65 years.
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateOctober 2016
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Bioprojet
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02800083
- Official title
Show the full official title
A Multisite Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Pitolisant (BF2.649) For Alcohol Use Disorder Treatment
Recruitment & locations
WithdrawnLocations not listed
Questions about this study
What is this study about?
Researchers are comparing Pitolisant (BF2.649) and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Who is behind this study?
The study sponsor is Bioprojet.
Does this study involve medication?
Yes. The study involves medication, including Pitolisant (BF2.649) and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
